MET targeted therapy for lung cancer: clinical development and future directions
Yan Feng,1,2 Patrick C Ma1–31Translational Hematology and Oncology Research, 2Solid Tumor Oncology, 3Aerodigestive Oncology Translational Research, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USAAbstract: MET, the receptor for hepatocyte growth factor, has been identified...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/1198cbd4fa954096b42e0400a73a3c59 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|